Prognostic value of tumor volume for patients with advanced lung cancer treated with chemotherapy

Lung cancer is the most common cause of cancerous death [1]. An irregular tumor is formed by continuous proliferation and division of cells that result from a mutation of pulmonary cells, and is further classified into small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). The latter accounts for about 85% of all lung cancers, and 25 ∼30% of NSCLC patients are diagnosed as being in the terminal stage on their first visit, while 40%∼50% of patients are found to have distant metastasis [2,3].

Source: Computer Methods and Programs in Biomedicine - March 30, 2017 Category: Bioinformatics Authors: Chung-Feng Jeffrey Kuo, Bo-Han Ke, Nain-Ying Wu, Joseph Kuo, Hsian-He Hsu Source Type: research